Overview
Status
Active
Registry date
2023-09-18
Share capital
5,000.00 PLN
Registered address
ul. Ekonomiczna 8, 99-400 Łowicz, Poland
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $38,465 |
Filing timeliness
Financial statements were filed on time, on average 9 days early.
- 202503/07/2026
- 202410/07/2025
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 2.33mMedianUSD 55.24kAverageUSD 2.71m
Net profit
This companyUSD 61.03kMedianUSD -1.27kAverageUSD -91.85k
Operating costs
This companyUSD 2.23mMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 781.19kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Tomasz Krzysztof Krasiński – Management Board Member
Robert Łukasz Łukasiewicz – Management Board Member
Manner of representation
Each member of the management board is authorised to make declarations of will on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Tomasz Krzysztof Krasińskiage 43 | 50 | $675.31 | 50% |
Robert Łukasz Łukasiewiczage 46 | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedappS.A. | $3,351,163.61 | medapp.pl | ||
| BiotechnaS.A. | $2,472,888.07 | bsbiotechna.com | ||
| Read-GeneS.A. | $2,163,474.84 | read-gene.com | ||
| Proteon PharmaceuticalsS.A. | $2,026,826.52 | proteonpharmaspolkaakcyjna.pl | ||
| SkinlabP.S.A. | $1,797,229.06 | skinlab.pl | ||
| EIT Rawmaterials Clc Eastsp. z o.o. | $1,795,803.10 | eitrawmaterials.eu | ||
| RDLSsp. z o.o. | $1,680,515.32 | rdls.pl | ||
| Centrum Badań Weterynaryjnych Vetcomplexsp. z o.o. | $255,522.81 | vetcomplex.pl | ||
| UveraS.A. | $155,384.29 | uvera.eu | ||
| Luna Laboratorysp. z o.o. | $61,894.23 | lunalab.pl |
FAQ
The main business activity of Biozero focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on September 18, 2023.
The headquarters is located at: ul. Ekonomiczna 8, 99-400 Łowicz.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from August 30, 2023 to December 31, 2024.
The company reported a revenue of $5,322 in 2024.
Yes, in 2024 the company achieved a net profit of $334.
The largest operating cost category falls under other operating costs. This category amounted to $4,762 in 2024, representing 100% of all operating expenses.
Last updated: 2026-07-06
